TBI Diagnostics EyeStat offers a rapid, FDA-cleared blink reflex assessment with objective data, presenting a sales opportunity to hospitals, clinics, and trauma centers focused on traumatic brain injury diagnosis and management.

Neurodegenerative Expansion Beyond TBI, the technology shows potential in differentiating and monitoring neurological conditions like Parkinson's, Alzheimer's, and migraines, enabling cross-sell to neurology and CNS departments.

Clinical Validation Recent Series C funding and FDA-cleared status bolster credibility for purchaser conversations; emphasize proven concept data and readiness for integration into clinical workflows.

Tech Stack Fit Existing digital capabilities (WordPress, analytics, CRM automation) suggest a lean, software-enabled sales approach; highlight compatibility with electronic medical records and data visualization needs.

Growth Signals Funding momentum and a small but focused team indicate a nimble partner for pilot programs in medical centers and research institutions seeking innovative CNS assessment tools.